
High-Profile Move: Citigroup ECM Veteran Abrahimzadeh Joins 1789 Capital
In a significant shift within the finance sector, Sadiq Abrahimzadeh, a veteran in equity capital markets at Citigroup, has announced his departure from the banking giant to join 1789 Capital, a private equity firm helmed by the prominent investor, Malik. This move is expected to create a ripple effect in investment circles, as Abrahimzadeh brings with him a wealth of experience and an expansive network that could bolster 1789 Capital's strategic initiatives.
Continue reading
Malik's Bold Move: 1789 Capital Invests in Controversial Drug Startup BlinkRx
In a striking development within the pharmaceutical investment landscape, 1789 Capital, under the leadership of co-founder and activist investor Vivek Malik, has announced a significant investment in BlinkRx, a drug startup that is rapidly making waves for its unique business model and strong ideological stance. This partnership is not just about financial backing; it also exemplifies Malik's commitment to moving against the prevailing “woke” culture that he believes has stifled innovation and growth in the industry.
Continue reading